Douglas Freedberg, MD
Sports Medicine · Scottsdale, AZNPI 1497751283
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Think Surgical, Inc. accounts for 65.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $9,261 and has fallen 97.5% since, to $228 in 2025.
Across 81 payments — averaging $204.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Think Surgical, Inc.$11K
- Arthrex$3K
- Impactortho, Inc.$2K
- Vericel Corporation$437
- Smith+Nephew$395
- Goode Surgical Inc$192
- plus $296 from 5 others
What the payments were for
- Consulting fees$9,10055%
- Travel & lodging$3,74323%
- Food & beverage$2,53815%
- Education$1,2007%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Think Surgical, Inc. | 6 | $10,873 |
| Arthrex | 41 | $2,684 |
| Impactortho, Inc. | 4 | $1,704 |
| Vericel Corporation | 7 | $437 |
| Smith+Nephew | 10 | $395 |
| Goode Surgical Inc | 1 | $192 |
| Motive Health, Inc. | 4 | $115 |
| Johnson & Johnson | 5 | $108 |
| Arteriocyte Medical Systems, Inc. | 1 | $34 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,582 in reported general payments places this provider in the 80th percentile of 152 sports medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 46 | $311 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $169 |
| Naproxen | 49 | $118 |
| Tramadol Hcl | 53 | $92 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Scottsdale
- Amon FerryScottsdale$482K
- John TokishScottsdale$387K
- Jordan LilesScottsdale$51K
- James ShahaScottsdale$31K
- Anikar ChhabraScottsdale$21K
- Brent RichScottsdale$12K
- Matthew GulbrandsenScottsdale$9K
- Karan PatelScottsdale$8K
- Angelo MattalinoScottsdale$7K
- Lance WinterScottsdale$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.